¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Progress in cell cycle research."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® ovulation cycle ÇÑ±Û ¹è¶õÁÖ±â
¼³¸í   
  »çÃá±â°¡ µÇ¾î ³­¼Ò°¡ ³úÇϼöüÀü¿±À¸·ÎºÎÅÍÀÇ »ý½Ä»ùÀÚ±ØÈ£¸£¸óÀÇ ÀÛ¿ëÀ» ¹Þ¾Æ ¿ø½Ã³­Æ÷°¡ ¹ßÀ°ÇÏ°í ¼º¼÷³­Æ÷°¡ µÈ´Ù. °á±¹¿¡´Â ³­Æ÷º®ÀÌ ÆÄ¿­µÇ¾î °ú¸³¸·¼¼Æ÷·Î µÑ·¯½ÎÀΠ³­ÀÚ°¡ º¹°­³»·Î ¹èÃâµÈ´Ù(¹è¶õ). ¹è¶õ ÈÄ 24~96½Ã°£À¸·Î °ú¸³¸·¼¼Æ÷°¡ ºñ´ëÁõ½ÄÇØ¼­ È²Ã¼¸¦ Çü¼ºÇÑ´Ù. ¼öÁ¤µÇÁö ¾ÊÀº °æ¿ì ¿ù°æÈ²Ã¼´Â ¾à 10Àϰ£ Á¸¼ÓÇϰí ÅðÇຯ¼ºÇؼ­ ¹éü°¡ µÈ´Ù. È²Ã¼°¡ ÅðÇຯ¼ºÇϸ頴ÙÀ½ÀÇ ³­Æ÷°¡ ¼º¼÷ÇÑ´Ù. ³­¼Ò¿¡¼­´Â ÀÌ ÁֱⰡ ¹Ýº¹µÇ°í ÀÖ´Ù.
¿µ¹® VDRL(venereal disease research laboratory) ÇÑ±Û ¼ºº´ ¿¬±¸½ÇÇè½Ç
¼³¸í   
  ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
¿µ¹® muscle cell(=muscle fiber) ÇÑ±Û ±ÙÀ°¼¼Æ÷
¼³¸í   
  ±ÙÀ°Àº ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁö¸ç, ±ÙÀ°¼¼Æ÷ÀÇ ¸ð¾çÀº ´ÙÀ½°ú °°´Ù(¼öÀDZÙ, ºÒ¼öÀDZ٠¿Ü¿¡ ½ÉÀå¿¡ Àִ ½ÉÀå±ÙÀº ºÒ¼öÀDZٿ¡ ÇØ´çÇÏÁö¸¸ ±× ¸ð¾çÀº ¼öÀDZٰú °°¾Æ µû·Î ºÐ·ùÇÑ´Ù).
  
  ±ÙÀ°¼¼Æ÷
¿µ¹® white blood cell(WBC), leukocyte ÇÑ±Û ¹éÇ÷±¸
¼³¸í   
  Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, È¤Àº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀΠÇö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù.
¿µ¹® mast cell ÇÑ±Û ºñ¸¸ ¼¼Æ÷
¼³¸í   
  µ¿¹°ÀÇ °áÇÕ Á¶Á÷ °¡¿îµ¥ ³Î¸® ºÐÆ÷Çϴ ¼¼Æ÷. °áÇÕÁ¶Á÷°ú Á¡¸·Á¶Á÷ ³»¿¡ Àִ ȣ¿°±â¼º »ö¼Ò·Î ÀÌ¿°»ö¼º(metachromasia)À» ³ªÅ¸³»´Â °ú¸³À» °¡Áø ¹æÃßÇüÀÇ ¼¼Æ÷¿¡ ÀÛÀº µÕ±Ù ÇÙÀ» °¡Áø´Ù. ºñ¸¸¼¼Æ÷ÀǠǥ¸é¿¡´Â IgE¿¡ ´ëÇÑ ¼ö¿ëü°¡ Á¸ÀçÇϸç, ¼ö¿ëü¿¡ °áÇÕÇÑ IgE ºÐÀڵ鳢¸® ´Ù°¡ÀÇ Ç׿ø¿¡ ÀÇÇØ ¼­·Î ¿¬°áµÇ¸é ºñ¸¸¼¼Æ÷ °ú¸³Å»Ãâ ¹ÝÀÀÀÌ ÀϾ, È÷½ºÅ¸¹Î, ¼¼·ÎÅä´Ñ, ÇìÆÄ¸° µîÀÇ È­ÇÐÀü´Þ ¹°ÁúÀÌ ¹æÃâµÇ¾î, Áï½ÃÇü ¾Ë·¹¸£±â ¹ÝÀÀ µîÀÇ Áõ»óÀ» ÀÏÀ¸Å²´Ù. ÇǺÎ, À帷, Ç÷°ü ÁÖÀ§, Á¡¸· ÁÖº¯¿¡ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research
    ¿¬±¸
  • research design
    ¿¬±¸°èȹ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç, VDRL°Ë»ç
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • anovulatory cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • anovulatory menstrual cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • aberrant cycle
    ÀÌ»óÁÖ±â
  • biologic cycle
    »ý¹°ÇÐÀûÁÖ±â
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î, ±¸¿¬»êȸ·Î
  • carbon dioxide cycle
    ÀÌ»êȭź¼Òȸ·Î
  • Cori cycle
    ÄÚ¸®È¸·Î
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cycle
    1. ÁÖ±â 2. ¼øÈ¯ 3. ȸ·Î 4. °í¸® 5. Á֯ļö
  • cardiovascular cycle
    ½ÉÀåÇ÷°üÁÖ±â
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research
    ¿¬±¸
  • diagnostic research
    Áø´Ü¿¬±¸
  • cycle
    ÁÖ±â, ¼øÈ¯, ȸ·Î, Á֯ļö
  • anovulatory menstrual cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • infection cycle
    °¨¿°°í¸®, °¨¿°»ç
  • ovulation cycle
    ¹è¶õÁÖ±â
  • reproduction cycle
    »ý½ÄÁÖ±â
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • cell
    ¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
  • amacrine cell
    ¹«Ãà»è¼¼Æ÷
  • balloon cell
    dz¼±¼¼Æ÷
  • basal cell
    ¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
  • basal cell carcinoma
    ¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • research design
    ¿¬±¸°èȹ
  • operational research
    ÀÛÀü¿¬±¸
  • research
    ¿¬±¸
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • aberrant cycle
    ÀÌ»ó¼øÈ¯
  • anovulatory cycle
    ¹«¹è¶õ¿ù°æÁÖ±â
  • anovulatory menstrual cycle
    ¿ù°æÁÖ±â, ¹«¹è¶õ¼º
  • biologic cycle
    »ý¹°ÇÐÀûÁÖ±â
  • cycle
    ÁÖ±â, ¼øÈ¯, ȸ·Î, Á֯ļö
  • cardiovascular cycle
    ½ÉÀåÇ÷°üÁÖ±â
  • citric acid cycle
    ±¸¿¬»êȸ·Î, ½ÃÆ®¸£»êȸ·Î
  • cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â
  • cycle life
    »ýȰ»ç, »ýȰÁÖ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lipid Research Clinic
    ÁöÁú¿¬±¸Áø·á¼Ò
  • RDC, see Research Diagnostic Criteria
    ¿¬±¸Áø´Ü±âÁØ, ¿¬±¸¿ë Áø´Ü±âÁØ
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • Cross bridge cycle
    ±³Â÷°áÇÕÁÖ±â(Îßó©Ì¿ùêñÎÑ¢)
  • Cycle AMP
    °í¸®¸ð¾çAMP, ȯ½Ä¾Æµ¥³ë½Å¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀÌŬ¸¯AMP
  • Cycle GMP
    °í¸®¸ð¾çGMP, ȯ½Ä±¸¾Æ³ë½Å¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀÌŬ¸¯GMP
  • Krebs cycle
    Å©·¾½º ȸ·Î.
  • Krebs cycle
    Å©·¹ºê½º ÁÖ±â(¡­ñÎÑ¢)
  • Krebs cycle
    Å©·¹ºêÁÖ±â
  • aberrant cycle
    ÀÌ»ó¼øÈ¯(ì¶ßÈâàü»)
  • anovulatory cycle
    ¹«¹è¶õ ¿ù°æÁÖ±â(ÙíÛÉÕ°êÅÌèñ²Ñ¢)
  • anovulatory cycle
    ¹«¹è¶õ¼º ÁÖ±â(ÙíÛÉÕ°àõ ñÎÑ¢)
  • anovulatory cycle
    ¹«¹è¶õ¼º ÁÖ±â.
  • gastric cycle
    À§ÁÖ±â(êÖñÎÑ¢).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
  • research diagnostic criteria(RDC)
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • schizogenic cycle ; schizogenous cycle
    ºÐ¿­È¯(ÝÂÖ®ü»)
  • cell cycle
    ¼¼Æ÷ÁÖ±â(¡­ñ²Ñ¢)
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • cell cycle
    ¼¼Æ÷ÁÖ±â(¡­ñ²Ñ¢).
  • cell cycle
    ¼¼Æ÷ÁÖ±â
  • cell cycle time
    ¼¼Æ÷ÁÖ±â½Ã°£
  • tumor growth,cell cycle and
    ¼¼Æ÷ÁÖ±â¿Í ¡­
  • aberrant cycle
    ÀÌ»ó¼øÈ¯(ì¶ßÈâàü»)
  • anovulatory cycle
    ¹«¹è¶õ ¿ù°æÁÖ±â(ÙíÛÉÕ°êÅÌèñ²Ñ¢)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Mode and course of progress
    ÁøÇà¾ç½Ä ¹× °úÁ¤
    [¿¾ ¿ë¾î] ÁøÇà¾ç½Ä¹×°úÁ¤
  • Cell cycle
    ¼¼Æ÷ÁÖ±â
    [¿¾ ¿ë¾î] ¼¼Æ÷ÁÖ±â
  • Ovarian cycle
    ³­¼ÒÁÖ±â
    [¿¾ ¿ë¾î] ³­¼ÒÁÖ±â
  • Male reproductive cycle
    ³²¼º»ý½ÄÁÖ±â
    [¿¾ ¿ë¾î] ³²¼º»ý½ÄÁÖ±â
  • Female reproductive cycle
    ¿©¼º»ý½ÄÁÖ±â
    [¿¾ ¿ë¾î] ¿©¼º»ý½ÄÁÖ±â
  • Menstrual cycle
    ¿ù°æÁÖ±â
    [¿¾ ¿ë¾î] ¿ù°æÁÖ±â
  • Gravitational cycle
    ÀÓ½ÅÁÖ±â
    [¿¾ ¿ë¾î] ÀÓ½ÅÁÖ±â
  • Spermatogenic cycle
    Á¤Àڹ߻ýÁÖ±â
    [¿¾ ¿ë¾î] Á¤Àڹ߻ýÁÖ±â
  • Mammary cycle
    Á¥»ùÁÖ±â
    [¿¾ ¿ë¾î] À¯¼±ÁÖ±â
  • Vaginal cycle
    ÁúÁÖ±â
    [¿¾ ¿ë¾î] ÁúÁÖ±â
  • Cycle of ontogenesis
    °³Ã¼¹ß»ýÁÖ±â
    [¿¾ ¿ë¾î] °³Ã¼¹ß»ýÁÖ±â
  • Mitotic cycle
    À¯»çºÐ¿­ÁÖ±â
    [¿¾ ¿ë¾î] À¯»çºÐ¿­ÁÖ±â
  • Estrous cycle
    ¹ßÁ¤ÁÖ±â
    [¿¾ ¿ë¾î] ¹ßÁ¤ÁÖ±â
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷(Á¦1Çü»ç±¸¼¼Æ÷)
  • Clear cell [Epinephrine cell]
    ¹àÀº¼¼Æ÷ [¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¸í¼¼Æ÷(¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • enteroepithelial cycle
    Àå»óÇǼ¼Æ÷³»»ýȰ»ç
  • erythrocytic cycle
    ÀûÇ÷±¸³»¹ßÀ°È¯
  • exo-erythrocytic cycle
    ÀûÇ÷±¸¿Ü¹ßÀ°È¯
  • free-living cycle
    ÀÚÀ¯»ýȰȯ
  • life cycle
    »ýȰ»ç
  • sylvatic life cycle
    ¹Ð¸²»ýȰȯ
  • excretory cell
    ¹è¼³¼¼Æ÷
  • flame cell
    ºÒ²É¼¼Æ÷
  • G cell G
    ¼¼Æ÷
  • germ cell
    ¹è¼¼Æ÷
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
  • nurse cell
    º¸¸ð¼¼Æ÷
  • renette cell
    ¹è¼³¼¼Æ÷
  • tegumental cell
    Ç¥ÇǼ¼Æ÷
  • vitelline cell
    ³­È²¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • progress curve
    ÁøÇà°î¼±(òäú¼ÍØàÊ)
  • cell cycle
    ¼¼Æ÷ÁÖ±â(á¬øàñÎÑ¢)
  • acetylornithine cycle
    ¾Æ¼¼Æ¿¿À¸£´Ïƾ ȸ·Î(üÞÖØ)
  • arginine cycle
    ¾Æ¸£Áö´Ñ ȸ·Î(üÞÖØ)
  • ATP-ADP cycle
    ATP-ADP ȸ·Î(üÞÖØ)
  • C4 acid cycle
    C4 »ê(ß«) ȸ·Î(üÞÖØ)
  • Calvin cycle
    Ä®ºó ȸ·Î(üÞÖØ)
  • carbon cycle
    ź¼Ò ȸ·Î(÷©áÈüÞÖØ)
  • carbon-fixation cycle
    ź¼Ò°íÁ¤ ȸ·Î(÷©áÈͳïÒüÞÖØ)
  • carbon-oxygen cycle
    ź¼Ò»ê¼Ò ȸ·Î(÷©áÈß«áÈüÞÖØ)
  • carbon reduction cycle
    ź¼Ò ȯ¿ø ȸ·Î(÷©áÈü½êªüÞÖØ)
  • citrate cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • citrate-pyruvate cycle
    ½ÃÆ®¸£»ê(ß«)-ÇǸ£ºê»êȸ·Î(ß«üÞÖØ)
  • citric acid cycle
    ½ÃÆ®¸£»êȸ·Î(ß«üÞÖØ)
  • Cori cycle
    ÄÚ¸® ȸ·Î(üÞÖØ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • progress
    °æ°ú
  • anovulatory cycle
    ¹«¹è¶õ¼ºÁÖ±â
  • cardiac cycle
    ½ÉÀåÁÖ±â
  • cycle
    ÁÖ±â, »çÀÌŬ, ¼øÈ¯, ȸ·Î
  • duty cycle
    µ¿ÀÛºñÀ²
  • life cycle
    »ýȰȯ, »ýȰ ÁÖ±â
  • ovulation cycle
    ¹è¶õÁÖ±â
  • pulse cycle
    ¸Æ¹ÚÁÖ±â
  • acinar cell
    Æ÷»ó¼¼Æ÷
  • air cell
    ÇԱ⵿
  • alveolar cell carcinoma
    ÆóÆ÷¼¼Æ÷¾ÏÁ¾
  • basal cell carcinoma
    ±âÀú¼¼Æ÷¾ÏÁ¾
  • blast cell
    ¸ð¼¼Æ÷
  • blood cell
    Ç÷±¸
  • cell
    ¼¼Æ÷, ¹úÁý, ºÀ¼Ò, °ÇÀüÁö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MC mass casualties; mast cell; Master of Surgery [Lat. Magister Chirurgiae]; maximum concentration; Med...
PC avoirdupois weight [Lat. pondus civile]; packed cells; paper chromatography; paracortex; parent cell...
FTP Failure To Progress, where dilation stalls or labor does not progress fast enough in the provider's ...
FLC family life cycle; fatty liver cell; fetal liver cell; Friend leukemia cell
FEDRIP Federal Research in Progress [database]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
cdc Cell division cycle
CDC2 cell division cycle 2
cpd 1-cycle-per-degree
cpm cycle per minute
BRAC BASIC REST ACTIVITY CYCLE
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 20936
    JournalTitle: Progress in cell cycle research.
    MedAbbr: Prog Cell Cycle Res
    ISSN: 1087-2957
    ESSN:
    IsoAbbr:
    NlmId: 9609058
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • abortion in progress
    ÁøÇà À¯»ê
    Àڱà ÃâÇ÷ÀÌ ¸¹°í º¹ÅëÀÌ ÀÖ´Â °ÍÀÌ Æ¯Â¡À̸ç Àڱà °æºÎÀÇ ¿¬È­¿Í È®ÀåÀ» ¼ö¹ÝÇϸç À¯»êµÈ´Ù.
  • progress of disease
    º´ÀÇ °æ°ú, º´ÀÇ ÁøÇà
    Áúº´ÀÌ ¾ÕÀ¸·Î ÁøÇàÇÏ¿© ¿øÇÏÁö ¾Ê´Â °á°ú¸¦ ÃëÇÏ´Â °Í
  • clinical research
    ÀÓ»ó ¿¬±¸
  • pain research laboratory
    µ¿Åë ¿¬±¸¼Ò
  • preclinical research
    ÀÓ»ó Àü ¿¬±¸
  • research
    ¿¬±¸, Á¶»ç
  • The National Institute of Dental Research
    ±¹¸³ Ä¡ÀÇÇÐ ¿¬±¸¼Ò
  • VDRL : Venereal Disease Research LaboratoryÀÇ ¾àÀÚ. ¸Åµ¶±ÕÀÇ Reagin¿¡ ´ëÇÑ Ç×ü·Î, ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ°¡ Ä¡·á È¿°ú ÆÇÁ¤¿¡ »ç¿ëµÈ´Ù. ¸Åµ¶ ¿Ü¿¡µµ Àü½Å¼º È«¹Ý¼º ³¶Ã¢(SLE), ·ù¸¶ÅäÀÌµå °üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
    VDRL ¸é»ó ¹ÝÀÀ
  • cell cycle-non specific
    ¼¼Æ÷ Áֱ⠺ñƯÀ̼º Á¦Á¦
  • aberrant cycle
    ÀÌ»ó ¼øÈ¯
    ½Â¸ðÆÇ ÇùÂø ¶§¹®¿¡ °£ Ç÷°ü°ú ±â°üÁö Ç÷°üÀÌ ±³ÅëÇÏ´Â °Í.
  • biologic cycle
    »ý¹°ÇÐÀû ÁÖ±â
  • cardiac cycle
    ½ÉÀå ÁÖ±â, ½É ÁÖ±â
    ½É¹æ°ú ½É½ÇÀº ½Ã°£ÀûÀ¸·Î µ¿½Ã´Â ¾Æ´ÏÁö¸¸ ¼öÃà°ú È®ÀåÀ» °ÅµìÇϰí ÀÖ°í, ÀÌ ÁÖ±âÀûÀΠȰµ¿ÀÌ ½É¹Úµ¿ÀÌ°í ½É¹Úµ¿ÀÇ Áֱ⸦ ½ÉÁÖ±â¶ó°í ÇÑ´Ù.
  • cardic cycle
    ½ÉÁÖ±â
    ¿Ï°áµÈ ½É¿îµ¿ ¶Ç´Â ½É¹Ú. ¾î¶² ½É¹ÚÀÇ ½ÃÀÛºÎÅÍ ´ÙÀ½ ½É¹ÚÀÇ ½ÃÀÛ±îÁöÀÇ ±â°£. ¼öÃß±â, È®Àå±âÀÇ ¿îµ¿°ú ±×°ÍµéÀÇ °£°Ý.
  • cash cycle
    ÀÚ±Ý È¸Àü
    ¿øÀÚÀçÀÇ ±¸¸Å·ÎºÎÅÍ ÃÖÁ¾ »ý»ê¹°ÀÇ ÆÇ¸Å¿¡¼­ ¹ß»ýÇÏ´Â °è»êÀÇ Çհ踦 ³¾ ¶§±îÁö °É¸®´Â ½Ã°£.
  • chronic pain cycle
    ¸¸¼º µ¿Åë ¼øÈ¯
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
progress 1. A moving or going forward; a proceeding onward; an advance; specifically: In actual space, as the progress of a ship, carriage, etc.
In the growth of an animal or plant; increase.
In business of any kind; as, the progress of a negotiation; the progress of art.
In knowledge; in proficiency; as, the progress of a child at school.
Toward ideal completeness or perfection in respect of quality or condition; applied to individuals, communities, or the race; as, social, moral, religious, or political progress.
2. A journey of state; a circuit; especially, one made by a sovereign through parts of his own dominions. "The king being returned from his progresse." (Evelyn)
Origin: L. Progressus, from progredi, p. P. Progressus, to go forth or forward; pro forward + gradi to step, go: cf. F. Progres. See Grade.
Source: Websters Dictionary
(01 Mar 1998)
progress curve A graphical representation of a chemical or enzyme-catalyzed reaction in which the product concentration or the substrate concentration or the ES binary complex are plotted against time.
(05 Mar 2000)
progress zone An undifferentiated population of mesenchyme cells beneath the apical ectodermal ridge of the chick limb bud from which the sucessive parts of the limb are laid down in a proximo distal sequence.
(18 Nov 1997)
cell cycle <cell biology, molecular biology> The sequence of events between mitotic divisions. The cycle is conventionally divided into G0, G1, (G standing for gap), S (synthesis phase during which the DNA is replicated), G2 and M (mitosis).
Cells that will not divide again are considered to be in G0 and the transition from G0 to G1 is thought to commit the cell to completing the cycle and dividing.
(26 Mar 1998)
cell cycle proteins Proteins that control the cell division cycle. This family of proteins includes a wide variety of classes, including cyclin-dependent kinases, mitogen-activated kinases, cyclins, and phosphoprotein phosphatases (phosphoprotein phosphatase) as well as their putative substrates such as chromatin-associated proteins, cytoskeletal proteins, and transcription factors.
(12 Dec 1998)
cell cycle restriction point <cell biology, molecular biology> A point, late in G1, after which the cell must, normally, proceed through to division at its standard rate.
(26 Mar 1998)
cell division cycle gene Genes which control the yeast cell cycle. There are around 50 different genes which do this.
(09 Oct 1997)
cell division cycle mutant A yeast cell which has cell division cycle genes that have mutated to become sensitive to temperature, at certain temperatures (usually high ones), various parts of the normal yeast cell cycle become abnormal, and in some strains the yeast cell does not survive at all.
(09 Oct 1997)
Venereal Disease Research Laboratory <microbiology> A blood test used to diagnose syphilis.
Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy.
Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies).
(12 Jan 1998)
Medical Research Council <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom.
It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases.
(05 Jan 1998)
research Careful, a diligent search, a close searching, studious inquiry or examination.
(18 Nov 1997)
research, controlled The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured.
(12 Dec 1998)
research design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
(12 Dec 1998)
research personnel Those individuals engaged in research.
(12 Dec 1998)
research support Financial support of research activities.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell cycle
    ¼¼Æ÷ÁÖ±â;ºÐ¿­ÁÖ±â
  • progress
    ÁøÇà,Áøº¸,°æ°ú,ÁøÇàÇÏ´Ù
  • progress
    ÀüÁø;Áøº¸;¹ß´Þ(in progress ÁøÇàÁß, make progress ÁøÇàÇÏ´Ù);ÀüÁøÇÏ´Ù;ÀüÁø(ÁøÇà,Áøº¸)ÇÏ´Ù;ÀüÁø(ÁøÃ´)½ÃŰ´Ù
  • progress chaser
    (°øÀå µîÀÇ) ÁøÃ´ °¨µ¶ÀÚ
  • progress payment
    ÇÁ·Î±×·¹½º ÆäÀÌ¸ÕÆ®(ÀÏÀÇ ÁøÃ´µµ¿¡ µû¶ó ÁöºÒµÇ´Â ´ë±Ý)
  • rake's progress
    ¹æÅÁÀÚÀÇ ÃßÀÌ(°á±¹ ¸ÁÇϱâ)
  • research
    ¿¬±¸
  • listener research
    Àαâ ÇÁ·ÎÁ¶»ç
  • market research
    (Á¦Ç°À» ¸ÅÃâÇϱâ ÀüÀÇ) ½ÃÀå Á¶»ç
  • market research
    ½ÃÀå Á¶»ç (¾î¶² »óǰÀÇ ¼ö¿ä¸¦ À§ÇÑ »çÀü Á¶»ç)
  • marketing research
    ½ÃÀå Á¶»ç;½ÃÀå ºÐ¼®
  • motivational research
    µ¿±â Á¶»ç
  • operations research
    ±â¾÷ °æ¿µ»óÀÇ °úÇÐÀû Á¶»ç ¿¬±¸;ÀÛÀü ¿¬±¸
  • research
    (Çмú)¿¬±¸;°úÇÐÀû ޱ¸;ÇмúÁ¶»ç;(½ÅÁßÇÑ)¼ö»ö;ޱ¸;Á¶»ç;¿¬±¸ ´É·Â;¿¬±¸½É;¿¬±¸ÇÏ´Ù;Á¶»çÇÏ´Ù;~able
  • research and development
    ¿¬±¸¿Í °³¹ß
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á